Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Healthc (Amst). 2019 Apr 26;7(4):S2213-0764(18)30230-6. doi: 10.1016/j.hjdsi.2019.04.003

Table 2:

Area Under the Curve (C-Statistic) of the Modified RxRisk-V Index (RxRisk-VM) in Comparison to and in Combination with Commonly Used Diagnostic Claims-Based Indices

1-year mortality (95% CI)* 3-year mortality (95% CI)*
Individual Models
 Baseline Demographics (Demo) 0.716 (0.713, 0.719) 0.729 (0.723, 0.731)
 Demo + Unique Prescription Count 0.744 (0.740, 0.747) 0.753 (0.751, 0.755)
 Demo + RxRisk-V (original weights) 0.759 (0.756, 0.762) 0.767 (0.765, 0.769)
Demo + RxRisk-VM (fully modified version) 0.773 (0.770, 0.776) 0.779 (0.778, 0.781)
 Demo + Charlson 0.794 (0.791, 0.797) 0.792 (0.790, 0.794)
 Demo + Elixhauser 0.800 (0.798, 0.803) 0.796 (0.793, 0.797)
 Demo + Gagne 0.810 (0.807, 0.813) 0.805 (0.803, 0.807)
Combined Models
 Demo + Charlson + RxRisk-VM 0.805 (0.802, 0.808) 0.803 (0.801, 0.805)
 Demo + Elixhauser + RxRisk-VM 0.812 (0.809, 0.815) 0.809 (0.807, 0.811)
 Demo + Gagne + RxRisk-VM 0.817 (0.814, 0.819) 0.813 (0.811, 0.815)
*

Models for 1-year and 3-year mortality were compared separately. All comparisons were statistically significant when applying the Chi Square Test of the AUC (p<0.001)

Baseline demographic models (demo) includes categorical age (10 categories: <50, 5-year categories between 50-89, and 90+), gender, race/ethnicity, Medicaid enrollment and disability status (original reason for Medicare enrollment).

Elixhauser Index excludes alcohol and drug use due to the redaction of related-claims.